Blood has an interesting retraction of a 2011 paper on what a group of authors claimed was a new cell line — but which proved, apparently, to be a chimera.
The article, “Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC,” came from a team at Universität Duisburg-Essen, in Germany, and has been cited 21 times, according to Thomson Scientific’s Web of Knowledge. Here’s the abstract: Continue reading Contaminated cells force retraction of Blood paper
A duo of former University of Queensland researchers have had a third article retracted following an investigation into 92 papers.
In September, Bruce Murdoch and Caroline Barwood had a paper in the European Journal of Neurology retracted. Earlier this month, the same happened to a paper in Aphasiology.
The retraction announced by the university today is for a 2013 paper in the International Journal of Speech-Language Pathology.
Here’s the notice, which is brief and behind a paywall: Continue reading University of Queensland investigation leads to third retraction
Two researchers at the University of Maryland who retracted a paper earlier this year for a duplicated figure have withdrawn another, this time for unknown reasons.
The Journal of Biological Chemistry (JBC) paper has been cited 16 times, according to Thomson Scientific’s Web of Knowledge.
Here’s the notice, for “Hsp90 Interaction with INrf2(Keap1) Mediates Stress-induced Nrf2 Activation,” which is unfortunately a return to the JBC’s opacity: Continue reading University of Maryland researchers notch second retraction
Another busy week at Retraction Watch, which kicked off with our announcement that we’re hiring a paid intern. Here’s what was happening elsewhere around the web: Continue reading Weekend reads: Self-plagiarism and moral panic; sexism in science; peer review under scrutiny
A group of authors at the University of Oklahoma have retracted a 2013 paper on ethics training after the university found that the data they used couldn’t be shared publicly.
Here’s the notice for “Improving Case-Based Ethics Training: How Modeling Behaviors and Forecasting Influence Effectiveness:” Continue reading Ethics training paper retracted because data couldn’t be shared
A former postdoc at the Mount Sinai School of Medicine in New York faked data in four published papers, one submitted manuscript, and four NIH grant applications, according to new findings by the Office of Research Integrity.
We reported on six retractions from Savio Woo’s Mount Sinai lab in 2010, from the Proceedings of the National Academy of Sciences (PNAS), the Journal of the National Cancer Institute, and two each from Human Gene Therapy and Molecular Therapy. The PNAS paper, as we noted then:
claimed to have discovered a possible cure for phenylketonuria, or PKU, in mice—a finding that was cited more than 30 times and trumpeted in the media.
At the time, Mount Sinai said that two of the lab’s postdocs had been dismissed for misconduct. Now, more than three and a half years later, the ORI reports that a former postdoc in that lab, Li Chen: Continue reading Former Mount Sinai postdoc faked gene therapy data: ORI
A group of authors in China has retracted their December 2013 paper in PLoS ONE after realizing that they’d been studying the wrong cells.
The paper, “Up-Regulation of pVHL along with Down-Regulation of HIF-1α by NDRG2 Expression Attenuates Proliferation and Invasion in Renal Cancer Cells,” came from Lei Gao, of the Fourth Military Medical University, in Xi’an, and colleagues. It purported to find that:
Continue reading Wrong cell line leads to retraction of kidney cancer study
An economics paper has been retracted after the journal that published it became aware that it contained plagiarism.
Here’s the notice: Continue reading “With deep regrets we apologize:” Economics paper retracted for plagiarism
Back in December, the University of Kansas issued a public censure of a former water researcher who, the school says, engaged in a pattern of plagiarism and other shoddy publishing practices.
Marios Sophocleous, who’d held the position of senior scientist at the Kansas Geological Survey:
Continue reading Retractions appear in case of former Kansas water scientist rebuked for misconduct
A group of researchers in Tokyo has lost their 2013 article in the Journal of Crystal Growth over commercial interests — which don’t appear to be their own.
We’ll explain.
The article, “Interactions between planar defects in bulk 3C-SiC,” came from a team consisting of a researcher at Keio University and scientists at two companies, HOYA Corporation, an optics firm, and SICOXS Corporation, which makes semiconductor wafers.
According to the abstract: Continue reading Crystal unclear? “Business decision” forces retraction of silicon paper